Ryo Morimura
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Gastric Cancer Management and Outcomes 27
- Metastasis and carcinoma case studies 10
- Hepatology 18
- Hepatocellular Carcinoma Treatment and Prognosis 18
- Co-authors
- Eigo Otsuji (122 shared papers)Hirotaka Konishi (111 shared papers)Atsushi Shiozaki (114 shared papers)Kazuma K. Okamoto (97 shared papers)Shuhei Komatsu (69 shared papers)Daisuke Ichikawa (57 shared papers)Hitoshi Fujiwara (106 shared papers)Masahiro Tsujiura (9 shared papers)
In The Last Decade
Ryo Morimura
131 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 1.6k
- Hepatology 194
- Oncology 566
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 392
Countries citing papers authored by Ryo Morimura
This map shows the geographic impact of Ryo Morimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Morimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Morimura more than expected).
Fields of papers citing papers by Ryo Morimura
This network shows the impact of papers produced by Ryo Morimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Morimura. The network helps show where Ryo Morimura may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryo Morimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 548 | |
| 2 | 2011 | 226 | |
| 3 | 2011 | 224 | |
| 4 | 2013 | 193 | |
| 5 | 2012 | 172 | |
| 6 | 2013 | 97 | |
| 7 | 2009 | 94 | |
| 8 | 2015 | 87 | |
| 9 | 2017 | 86 | |
| 10 | Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. | 2015 | 74 |
| 11 | 2015 | 58 | |
| 12 | 2016 | 56 | |
| 13 | 2017 | 56 | |
| 14 | 2014 | 53 | |
| 15 | 2019 | 48 | |
| 16 | 2014 | 43 | |
| 17 | 2016 | 32 | |
| 18 | 2013 | 27 | |
| 19 | 2014 | 27 | |
| 20 | 2020 | 26 |
About Ryo Morimura
Ryo Morimura is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Oncology, Surgery and Cancer Research, having authored 143 papers that have together received 3.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Esophageal Cancer Research and Treatment (18 papers), MicroRNA in disease regulation (11 papers), Metastasis and carcinoma case studies (10 papers), Colorectal Cancer Surgical Treatments (9 papers), Gastrointestinal Tumor Research and Treatment (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Cancer Research (1.6k citations), Hepatology (194 citations), Oncology (566 citations), Molecular Biology (1.3k citations) and Pulmonary and Respiratory Medicine (392 citations). Ryo Morimura has collaborated with scholars based in Japan, Germany and Greece. Frequent co-authors include Eigo Otsuji, Hirotaka Konishi, Atsushi Shiozaki, Kazuma K. Okamoto, Shuhei Komatsu, Daisuke Ichikawa, Hitoshi Fujiwara, Masahiro Tsujiura, Hisashi Ikoma and Toshiyuki Kosuga. Their work appears in journals such as Anticancer Research, British Journal of Cancer, Esophagus, Langenbeck s Archives of Surgery and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.